Infectious diseases Medicines Approved in the EU (EMA)

Medicines the European Medicines Agency has recommended for use in the European Union on this topic.

Each number has its full source under its own list below.

Medicines authorised in the EU

162 medicines (authorised now). Newest first. Each links to its EMA page.

At the source
  • Zokovea

    Active substance: ensitrelvir fumaric acid

    EMEA/H/C/006063
  • Xolremdi

    Active substance: mavorixafor

    EMEA/H/C/006496
  • Tuyory

    EMEA/H/C/006416
  • mCombriax

    Active substance: single-stranded, 5’-capped messenger RNAs (mRNAs) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding seasonal infl…

    EMEA/H/C/006472
  • mNexspike

    Active substance: single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding the N-terminal…

    EMEA/H/C/006428
  • VacPertagen

    Active substance: recombinant pertussis toxin;filamentous haemagglutinin

    EMEA/H/C/006304
  • Yeytuo

    Active substance: lenacapavir sodium

    EMEA/H/C/006658
  • Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris

    Active substance: emtricitabine;rilpivirine hydrochloride;tenofovir alafenamide fumarate

    EMEA/H/C/006491
  • Emtricitabine / Tenofovir alafenamide Viatris

    Active substance: emtricitabine;tenofovir alafenamide fumarate

    EMEA/H/C/006469
  • Deqsiga

    Active substance: human normal immunoglobulin

    EMEA/H/C/006423
  • Eltrombopag Accord

    Active substance: eltrombopag olamine

    EMEA/H/C/006459
  • Capvaxive

    Active substance: pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjuga…

    EMEA/H/C/006267
  • Avtozma

    Active substance: tocilizumab

    EMEA/H/C/006196
  • Kostaive

    Active substance: COVID-19 sa-mRNA Vaccine

    EMEA/H/C/006207
  • Kavigale

    Active substance: sipavibart

    EMEA/H/C/006291

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

Benchmarks on infectious diseases

Countries side by side on public measures for this topic.

All benchmarks

Acuitas market sizes and forecasts are only in our full reports. How we use public data.